Inhaled Budesonide Protects The Heart Of COPD Patients

Main Category: COPD
Also Included In: Cardiovascular / Cardiology
Article Date: 29 May 2007 - 12:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 and a half stars

4.29 (7 votes)

Healthcare Prof:5 stars

5 (1 votes)


Some studies have indicated that cardiac disease is related to general inflammation in COPD (chronic obstructive pulmonary disease). Therefore, Claes-Göran Löfdahl (Lund University Hospital, Lund, Sweden) and his North-European colleagues performed an analysis of 1,175 smoking patients who took part in a study initiated by the ERS (European Respiratory Society) more than 10 years ago.

In this EUROSCOP study (ERS study on chronic obstructive pulmonary disease), patients with mild COPD were treated for three years, either by placebo or by an inhaled corticosteroid budesonide 800 mg/day. The authors evaluated whether long-term budesonide treatment decreased the occurrence of cardio-ischaemic diseases, including angina pectoris, myocardial infarction and coronary artery disorder.

Claes-Göran Löfdahl and his team show findings of spontaneous reports of cardiac ischaemic diseases in 49 patients (4.2%) who experienced 60 cardio-ischaemic events. Patients treated with budesonide have a significantly lower incidence of cardio-ischaemic events (18 out of 593; 3.0%) than those receiving placebo (31 out of 532; 5.3%). The study also shows that the number of patients needing treatment with oral corticosteroids for COPD exacerbations decreased by 37%.
These results indicate that treatment with inhaled budesonide reduces cardio-ischaemic events in patients with mild COPD.

Title of the original article:
Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD
Journalists wishing for a copy of the article or its detailed references should e-mail erj@cedosinternational.com

The European Respiratory Journal is the peer-reviewed scientific publication of the European Respiratory Society (more than 8,000 specialists in lung diseases and respiratory medicine in Europe, the United States and Australia).

http://www.erj.ersjournals.com

Article adapted by Medical News Today from original press release.
Visit our copd section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Cristina Mesquida. "Inhaled Budesonide Protects The Heart Of COPD Patients." Medical News Today. MediLexicon, Intl., 29 May. 2007. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/72293.php>

APA
Cristina Mesquida. (2007, May 29). "Inhaled Budesonide Protects The Heart Of COPD Patients." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/72293.php.

Please note: If no author information is provided, the source is cited instead.


COPD

Most Popular Articles



Follow Our COPD News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our COPD Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »